☆ 4.7 Article

Characterizing the cellular and molecular variabilities of peripheral immune cells in healthy recipients of BBIBP-CorV inactivated SARS-CoV-2 vaccine by single-cell RNA sequencing

EMERGING MICROBES & INFECTIONS (2023)

Related references

Note: Only part of the references are listed.

Review Immunology

The T cell immune response against SARS-CoV-2

Paul Moss

Summary: T cell immunity plays a central role in controlling SARS-CoV-2 infection, with early responses correlating with protection. T cell memory provides broad recognition of viral proteins, limiting the impact of viral variants and offering protection against severe disease. Current COVID-19 vaccines elicit robust T cell responses, contributing to the prevention of hospitalization or death. Therefore, the importance of T cell immunity may have been underestimated.

NATURE IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Safety and immunogenicity of a third-dose homologous BBIBP-CorV boosting vaccination: interim results from a prospective open-label study

Jingwen Ai et al.

Summary: This study evaluated the safety and immunogenicity of a third homologous BBIBP-CorV booster vaccination in healthy adults. The results showed that this booster vaccination was safe and highly immunogenic, broadening participants' immunity against SARS-CoV-2 and Variants of Concern (VOCs).

EMERGING MICROBES & INFECTIONS (2022)

Add to Collection

Article Cell Biology

Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine

Yihao Liu et al.

Summary: SARS-CoV-2 inactivated vaccines have demonstrated significant efficacy in reducing severe illness and death. Despite a decline in humoral immunity over time, memory B and T cells remain detectable and can provide a quick recall response. A third booster dose enhances the immune response and improves the durability of protective immunity. Additionally, healthcare workers with low serological response to two doses still possess immune memory that can be quickly recalled by a third dose.

CELL DISCOVERY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Circadian nuclear receptor Rev-erbα is expressed by platelets and potentiates platelet activation and thrombus formation

Jianfeng Shi et al.

Summary: The study revealed that the circadian protein Rev-erb alpha is functionally expressed in platelets and enhances platelet activation and thrombus formation. This suggests that Rev-erb alpha could be a promising therapeutic target for managing thrombosis-related cardiovascular diseases.

EUROPEAN HEART JOURNAL (2022)

Add to Collection

Article Infectious Diseases

Serological reactivity of inactivated SARS-CoV-2 vaccine based on an S-RBD neutralizing antibody assay

Hui Zhang et al.

Summary: This study explored the regularity of S-RBD domain antibody reactivity after immunization with inactivated SARS-CoV-2 vaccine and found that the vaccine had a good effect on the immune response. Age and sex did not affect the positive rate, while the positive rate was lower in the high BMI group.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Article Medicine, General & Internal

Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults

Lianpan Dai et al.

Summary: The ZF2001 vaccine has been shown to be safe and effective against symptomatic and severe-to-critical Covid-19 in a large cohort of adults for at least 6 months after full vaccination.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Microbiology

Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile

Monica L. Acevedo et al.

Summary: The SARS-CoV-2 Lambda variant is prevalent in Latin America. Antibodies generated by CoronaVac and BNT162b2 were analyzed for their neutralizing capacity against SARS-CoV-2 Lambda in plasma samples from healthcare workers and patients in Chile. The study found that BNT162b2 elicits higher neutralizing antibody titres compared to CoronaVac. The study also identified mutations in the Lambda variant's spike protein that may contribute to immune escape.

NATURE MICROBIOLOGY (2022)

Add to Collection

Article Cell Biology

Immune repertoire analysis of normal Chinese donors at different ages

Cailing Song et al.

Summary: This study investigated the characteristics of the immune repertoire in normal Chinese individuals of different ages. The results showed that age significantly affected the T-cell receptor repertoire more than the B-cell receptor repertoire. These findings contribute to the treatment of age-related diseases and early-stage diagnosis.

CELL PROLIFERATION (2022)

Add to Collection

Article Immunology

Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case-control study

Vincent Ka Chun Yan et al.

Summary: Based on a case-control study using electronic health records, this research evaluated the effectiveness of CoronaVac and BNT162b2 vaccines in preventing mortality and severe complications after Omicron BA.2 infection. The study found that both vaccines were effective, and the risk of adverse outcomes decreased with the third dose, especially in individuals aged 65 and above.

EMERGING MICROBES & INFECTIONS (2022)

Add to Collection

Article Oncology

MIR548P and TRAV39 Are Potential Indicators of Tumor Microenvironment and Novel Prognostic Biomarkers of Esophageal Squamous Cell Carcinoma

Jian Xu et al.

Summary: Esophageal squamous cell carcinoma (ESCC) is a common aggressive malignancy, with certain functional genes in the tumor microenvironment playing a role in its progression. However, immune scores, stromal scores, and ESTIMATE scores were not found to be associated with overall survival of ESCC patients. Higher stromal scores were linked to more advanced tumor and clinical stages.

JOURNAL OF ONCOLOGY (2022)

Add to Collection

Article Cell Biology

Cellular basis of enhanced humoral immunity to SARS-CoV-2 upon homologous or heterologous booster vaccination analyzed by single-cell immune profiling

Jingwen Ai et al.

Summary: The study reveals the cellular mechanisms of booster-induced memory/adaptive humoral immunity. The heterologous booster can induce a faster and more robust plasmablast response, attributed to the recall of memory B cells and the activation of B cells. Expanded B cell clones can persist for months after booster dose vaccination.

CELL DISCOVERY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern

Tianhong Xie et al.

Summary: This study found that the prototypic SARS-CoV-2 inactivated vaccine provided protection against Alpha, Beta, Delta, and Omicron variants, reducing viral loads and improving lung pathology.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Add to Collection

Article Infectious Diseases

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

Shengli Xia et al.

Summary: The inactivated SARS-CoV-2 vaccine, BBIBP-CorV, demonstrated safety and immunogenicity in two age groups. Humoral responses against SARS-CoV-2 were induced in all vaccine recipients by day 42. A two-dose immunisation with 4 mu g vaccine on days 0 and 21 or days 0 and 28 achieved higher neutralising antibody titres compared to other dosing schedules.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Add to Collection

Article Multidisciplinary Sciences

A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein

Cheolmin Kim et al.

Summary: A human monoclonal antibody called CT-P59 has been shown to effectively neutralize SARS-CoV-2 and demonstrate significant therapeutic effects in animal models, making it a promising candidate for COVID-19 treatment.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Extremely potent human monoclonal antibodies from COVID-19 convalescent patients

Emanuele Andreano et al.

Summary: Human monoclonal antibodies have been identified as safe, preventive, and therapeutic tools against COVID-19. Through single-cell sorting from COVID-19 survivors, a large number of spike protein-specific memory B cells have been identified, leading to the discovery of highly effective neutralizing antibodies. The most potent monoclonal antibody, engineered to reduce risk and prolong half-life, has been shown to neutralize both the original virus and emerging variants.

CELL (2021)

Add to Collection

Article Biochemistry & Molecular Biology

COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas

Xianwen Ren et al.

Summary: The study revealed the presence of immune response dysfunction in COVID-19 patients, with different peripheral immune subtype changes associated with clinical features such as age, sex, severity, and disease stages. Additionally, dramatic transcriptomic changes were observed within virus-infected cells, and upregulation of S100A8/A9 in peripheral blood may contribute to the cytokine storms frequently observed in severe patients.

CELL (2021)

Add to Collection

Article Virology

Analysis of B Cell Receptor Repertoires Reveals Key Signatures of the Systemic B Cell Response after SARS-CoV-2 Infection

Yudi Zhang et al.

JOURNAL OF VIROLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Denis Y. Logunov et al.

Summary: The Gam-COVID-Vac vaccine showed 91.6% efficacy against COVID-19 in the phase 3 trial, with good safety and tolerability in a large cohort of participants.

LANCET (2021)

Add to Collection

Article Infectious Diseases

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Zhiwei Wu et al.

Summary: The study showed that CoronaVac vaccine is safe and well tolerated in older adults, and is able to induce neutralizing antibody levels. The highest dose of 3 μg of the vaccine can generate neutralizing antibody levels similar to the 6 μg dose, supporting the use of the 3 μg dose CoronaVac in phase 3 trials.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection

Review Microbiology

Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis

Santhamani Ramasamy et al.

Summary: COVID-19, caused by SARS-CoV-2, is a global pandemic with severe cases manifesting as acute respiratory distress syndrome, often in patients with underlying conditions. Rapid progression of the disease is mainly attributed to hyperinflammation and a lack of interferon response in the early stages.

CLINICAL MICROBIOLOGY REVIEWS (2021)

Add to Collection

Article Cell Biology

Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines

Jiping Liu et al.

Summary: Large-scale COVID-19 vaccinations are currently underway, causing consistent alterations in hemoglobin A1c, serum sodium and potassium levels, coagulation profiles, and renal functions in healthy volunteers. Single-cell mRNA sequencing also revealed changes in gene expression of immune cells, suggesting that vaccination mimics infection. Increased NF-kappa B signaling and reduced type I interferon responses were observed, indicating caution is needed when vaccinating individuals with pre-existing clinical conditions.

CELL DISCOVERY (2021)

Add to Collection

Article Cell Biology

Dynamics of TCR repertoire and T cell function in COVID-19 convalescent individuals

Lingjie Luo et al.

Summary: The study revealed that the diversity of TCR repertoire in discharged COVID-19 patients increased but returned to baseline level about one week after virus clearance, with the dynamics of T cell repertoire correlated with gene signature changes. Top expanded T cell clones displayed key anti-viral features, confirming the critical role of antigen-specific T cells in fighting against SARS-CoV-2.

CELL DISCOVERY (2021)

Add to Collection

Article Medicine, Research & Experimental

Single-cell profiling of T and B cell repertoires following SARS-CoV-2 mRNA vaccine

Suhas Sureshchandra et al.

Summary: mRNA vaccines for SARS-CoV-2 have shown strong protection against severe disease, enhancing spike-specific B cells and robust CD4(+) T cell responses. However, CD8(+) T cell responses following vaccination were relatively weak and variable, with clonally expanded CD8(+) T cells observed.

JCI INSIGHT (2021)

Add to Collection

Letter Cell Biology

Time of day influences immune response to an inactivated vaccine against SARS-CoV-2

Hui Zhang et al.

CELL RESEARCH (2021)

Add to Collection

Article Virology

Type I Interferon Promotes Humoral Immunity in Viral Vector Vaccination

Chaojie Zhong et al.

Summary: This study highlights the role of type I interferon (IFN) signaling in promoting humoral immunity in poxviral vector vaccination, including the generation of antibodies, B-cell response, and T follicular helper (Tfh) response. Understanding and potentially modulating these pathways could help improve vaccine efficacy in viral vector vaccinations.

JOURNAL OF VIROLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Systems vaccinology of the BNT162b2 mRNA vaccine in humans

Prabhu S. Arunachalam et al.

Summary: The study found that vaccination with the Pfizer-BioNTech mRNA vaccine can induce immune responses against neutralizing antibodies and CD4, CD8 T cells of SARS-CoV-2. Booster vaccines can significantly enhance innate immune responses, and different innate pathways associated with CD8 T cells and neutralizing antibodies have been identified.

NATURE (2021)

Add to Collection

Article Medicine, General & Internal

Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study

Otavio Ranzani et al.

Summary: The study evaluates the effectiveness of the CoronaVac vaccine in the elderly population aged >= 70 years in Sao Paulo state, Brazil during widespread circulation of the gamma variant. The vaccine was found to significantly reduce the risk of symptomatic covid-19, hospital admissions, and deaths after completion of the two-dose regimen, but the effectiveness decreases with age among the elderly population.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Review Immunology

Influenza Viruses: Innate Immunity and mRNA Vaccines

SangJoon Lee et al.

Summary: The innate immune system serves as the first line of defense against influenza viruses, and mRNA vaccines are being explored as a promising alternative to traditional approaches due to their safety, cost-effectiveness, rapid development capabilities, and high efficacy. This review provides insights into the innate immune response to mRNA vaccination, as well as discusses the future directions and challenges in advancing this promising therapeutic approach.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Cell Biology

Integrated single-cell analysis revealed immune dynamics during Ad5-nCoV immunization

Qiqi Cao et al.

Summary: COVID-19, caused by SARS-CoV-2, is a severe global health threat, with vaccines being highly effective in combating it. By using scRNA/V(D)J-seq technology to study peripheral blood mononuclear cells from COVID-19 vaccine trial participants longitudinally, enhanced immune responses were observed, providing insights for assessing vaccine efficacy.

CELL DISCOVERY (2021)

Add to Collection

Article Immunology

Immunological mechanisms of vaccine-induced protection against COVID-19 in humans

Manish Sadarangani et al.

Summary: Most COVID-19 vaccines aim to induce immune responses, particularly neutralizing antibodies (NAbs), against the spike protein of the virus. mRNA vaccines have shown efficacy after just one dose, while adenovirus vaccines elicit polyfunctional antibodies and strong T cell responses. These findings suggest that protection may not solely rely on NAbs but also involve other immune effector mechanisms.

NATURE REVIEWS IMMUNOLOGY (2021)

Add to Collection

Letter Biochemistry & Molecular Biology

Sera proteomic features of active and recovered COVID-19 patients: potential diagnostic and prognostic biomarkers

Ling Leng et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection

Review Immunology

Regulatory T Cells and Human Disease

Shimon Sakaguchi et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)

Add to Collection

Review Cell Biology

Memory CD4(+) T Cells in Immunity and Autoimmune Diseases

Itay Raphael et al.

CELLS (2020)

Add to Collection

Review Immunology

In Vivo CD4(+) T Cell Differentiation and Function: Revisiting the Th1/Th2 Paradigm

Mikel Ruterbusch et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)

Add to Collection

Article Pharmacology & Pharmacy

Protective Efficacy of Inhaled BCG Vaccination Against Ultra-Low Dose Aerosol M. tuberculosis Challenge in Rhesus Macaques

Andrew D. White et al.

PHARMACEUTICS (2020)

Add to Collection

Review Immunology

The COVID-19 Cytokine Storm; What We Know So Far

Dina Ragab et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Immunology

Single-cell landscape of immunological responses in patients with COVID-19

Ji-Yuan Zhang et al.

NATURE IMMUNOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer's disease

Ji-Yeun Hur et al.

NATURE (2020)

Add to Collection

Article Medicine, General & Internal

Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Cheryl Keech et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years

Chadi M. Saad-Roy et al.

SCIENCE (2020)

Add to Collection

Review Immunology

T cell factor 1: A master regulator of the T cell response in disease

Giulia Escobar et al.

SCIENCE IMMUNOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes

Gabriele Pizzolato et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Add to Collection

Review Immunology

Ikaros Zinc Finger Transcription Factors: Regulators of Cytokine Signaling Pathways and CD4+ T Helper Cell Differentiation

Michael D. Powell et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Review Immunology

Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases

Theodore S. Kapellos et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Article Immunology

STAT5B: A Differential Regulator of the Life and Death of CD4+ Effector Memory T Cells

Sonia S. Majri et al.

JOURNAL OF IMMUNOLOGY (2018)

Add to Collection

Article Genetics & Heredity

KLRD1-expressing natural killer cells predict influenza susceptibility

Erika Bongen et al.

GENOME MEDICINE (2018)

Add to Collection

Review Immunology

TH2 cell development and function

Jennifer A. Walker et al.

NATURE REVIEWS IMMUNOLOGY (2018)

Add to Collection

Review Immunology

Single-cell RNA sequencing to explore immune cell heterogeneity

Efthymia Papalexi et al.

NATURE REVIEWS IMMUNOLOGY (2018)

Add to Collection

Article Immunology

Precursors of human CD4(+) cytotoxic T lymphocytes identified by single-cell transcriptome analysis

Veena S. Patil et al.

SCIENCE IMMUNOLOGY (2018)

Add to Collection

Review Virology

Roles of SAMHD1 in antiviral defense, autoimmunity and cancer

Miaomiao Li et al.

REVIEWS IN MEDICAL VIROLOGY (2017)

Add to Collection

Article Medicine, General & Internal

Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection

Steven Rockman et al.

EBIOMEDICINE (2017)

Add to Collection

Article Virology

Structure of an N276-Dependent HIV-1 Neutralizing Antibody Targeting a Rare V5 Glycan Hole Adjacent to the CD4 Binding Site

Constantinos Kurt Wibmer et al.

JOURNAL OF VIROLOGY (2016)

Add to Collection

Article Immunology

Immune cell subsets and their gene expression profiles from human PBMC isolated by Vacutainer Cell Preparation Tube (CPT™) and standard density gradient

Christopher P. Corkum et al.

BMC IMMUNOLOGY (2015)

Add to Collection

Article Immunology

LEF-1 and TCF-1 orchestrate TFH differentiation by regulating differentiation circuits upstream of the transcriptional repressor BcI6

Youn Soo Choi et al.

NATURE IMMUNOLOGY (2015)

Add to Collection

Article Immunology

Proinflammatory cytokine responses correspond with subjective side effects after influenza virus vaccination

Lisa M. Christian et al.

VACCINE (2015)

Add to Collection

Review Immunology

Pathways of Antigen Processing

Janice S. Blum et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)

Add to Collection

Editorial Material Medicine, General & Internal

被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

Add to Collection

Article Cell Biology

CD4 T cell-intrinsic IL-2 signaling differentially affects Th1 and Th17 development

Kenjiro Fujimura et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2013)

Add to Collection

Article Biochemistry & Molecular Biology

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

Tom M. Wilkinson et al.

NATURE MEDICINE (2012)

Add to Collection

Article Multidisciplinary Sciences

Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine

Scott G. Hansen et al.

NATURE (2011)

Add to Collection

Article Virology

Interleukin-1 Family Cytokines as Mucosal Vaccine Adjuvants for Induction of Protective Immunity against Influenza Virus

Hiroyuki Kayamuro et al.

JOURNAL OF VIROLOGY (2010)

Add to Collection

Article Immunology

STAT1 in peripheral tissue differentially regulates homing of antigen-specific Th1 and Th2 cells

Zamaneh Mikhak et al.

JOURNAL OF IMMUNOLOGY (2006)

Add to Collection

Review Oncology

The function of immunoglobulin A in immunity

JM Woof et al.

JOURNAL OF PATHOLOGY (2006)

Add to Collection

Review Immunology

Regulation of IL4 gene expression by T cells and therapeutic perspectives

M Li-Weber et al.

NATURE REVIEWS IMMUNOLOGY (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.